SO
EWTX icon

STRS Ohio’s Edgewise Therapeutics EWTX Stock Holding History

STRS Ohio’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$857K Buy
21,100
+14,200
+206% +$490K ﹤0.01% 800
2026
Q1 		$217K Buy
+6,900
New +$199K ﹤0.01% 1469
2025
Q3 		– Sell
-6,100
Closed -$80K – 2227
2025
Q2 		$80K Buy
6,100
+2,300
+61% +$33.2K ﹤0.01% 1930
2025
Q1 		$83.6K Sell
3,800
-4,400
-54% -$115K ﹤0.01% 1701
2024
Q4 		$219K Sell
8,200
-1,200
-13% -$38.2K ﹤0.01% 1474
2024
Q3 		$251K Sell
9,400
-5,400
-36% -$107K ﹤0.01% 1496
2024
Q2 		$267K Buy
14,800
+2,200
+17% +$38.4K ﹤0.01% 1475
2024
Q1 		$229K Buy
+12,600
New +$200K ﹤0.01% 1512
2022
Q1 		– Sell
-2,900
Closed -$44K – 2167
2021
Q4 		$44K Hold
2,900
– – ﹤0.01% 2021
2021
Q3 		$48K Hold
2,900
– – ﹤0.01% 2076
2021
Q2 		$61K Buy
+2,900
New +$79.3K ﹤0.01% 2074

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

STRS Ohio's EWTX Position: Q2 2026 in Review

STRS Ohio increased its Edgewise Therapeutics (EWTX) stake by 206% in Q2 2026, buying an estimated $490K and bringing the position to 21,100 shares worth $857K. The position accounts for ﹤0.01% of the portfolio, ranked #800.

STRS Ohio first reported a position in EWTX in Q2 2021 and has held it in 11 quarters since. 225 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • STRS Ohio held 21,100 shares of Edgewise Therapeutics worth $857K as of Q2 2026.
  • STRS Ohio bought 14,200 Edgewise Therapeutics shares in Q2 2026, an estimated $490K.
  • Edgewise Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #800 holding.
  • STRS Ohio first reported a position in Edgewise Therapeutics in Q2 2021 and has held it in 11 quarters since.
  • 225 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.